Donald Olds
Director/Board Member bei GOODFOOD MARKET CORP.
Vermögen: 99 617 $ am 31.03.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Neil Cuggy | M | 36 | 10 Jahre | |
Zohar Krivorot | M | 48 | 6 Jahre | |
Jonathan Ferrari | M | 36 | 10 Jahre | |
Eric Keller | M | - |
Response Pharmaceuticals, Inc.
Response Pharmaceuticals, Inc. BiotechnologyHealth Technology Response Pharmaceuticals, Inc. is a clinical-stage therapeutic development company that focuses on developing treatments for weight management and metabolic disease. The company is based in Falls Church, VA. The company's initial clinical focus is to help people taking antipsychotic medications for disabling mental illness combat weight gain and metabolic dysregulation that is endemic with these treatments. Response is developing RDX-002 as an adjunctive therapy for patients taking first-line antipsychotic therapy. The company was founded by Eric Keller, Paul Sweetnam. Eric Keller has been the CEO since incorporation. | - |
Nicholas Thadaney | M | 56 | 2 Jahre | |
Kelly Perlman | M | - |
Aifred Health, Inc.
Aifred Health, Inc. Packaged SoftwareTechnology Services Aifred Health, Inc. provides artificial intelligence to enhance treatment response in mental health. It offers treatment prediction, interpretability, patient data tracking, and electronic patient recods. The company was founded by Robert Fratila, Kelly Perlman and Sonia Israel and is headquartered in Montréal, Canada. | 7 Jahre |
Agustin Tristan Aldave | M | - | 3 Jahre | |
Noemi Follain | F | - | 4 Jahre | |
David Glickman | M | - |
Presagia Corp.
Presagia Corp. Packaged SoftwareTechnology Services Part of Absence Soft LLC, Presagia Corp. is a cloud-based solutions provider that helps organizations solve complex health and business problems. The private company is based in Montréal, Canada. Presagia Sports is the Canadian company's world-class athlete electronic health record system, leveraged by Olympic organizations, professional sports teams, performance arts organizations, sports medicine clinics, school districts, high schools, and universities to optimize how they manage athlete health. Presagia also provides cloud-based absence management solutions that enable employers to efficiently manage employee absence while complying with more than 500 federal, state, and local leave rules and 150 Canadian federal and provincial leave rules. Presagia integrates with customers' HR systems and automates leave processes, enabling organizations to increase efficiency, minimize absence, reduce cost, and improve compliance, while providing better customer service to employees. The company was founded in 1987 by David Glickman, and René Beaudoin has been the CEO of the company since 2021. Presagia was acquired by Absence Soft LLC on November 30, 2021. | 37 Jahre |
Roslane Aouameur | M | - | - | |
Mary Durocher | F | - | 4 Jahre | |
Lara Zink | F | - | 2 Jahre | |
Jacob M. Kay | M | 83 | 5 Jahre | |
Robert Fratila | M | - |
Aifred Health, Inc.
Aifred Health, Inc. Packaged SoftwareTechnology Services Aifred Health, Inc. provides artificial intelligence to enhance treatment response in mental health. It offers treatment prediction, interpretability, patient data tracking, and electronic patient recods. The company was founded by Robert Fratila, Kelly Perlman and Sonia Israel and is headquartered in Montréal, Canada. | 5 Jahre |
Nicholas Sosiak | M | - | 5 Jahre | |
Sonia Israel | F | - |
Aifred Health, Inc.
Aifred Health, Inc. Packaged SoftwareTechnology Services Aifred Health, Inc. provides artificial intelligence to enhance treatment response in mental health. It offers treatment prediction, interpretability, patient data tracking, and electronic patient recods. The company was founded by Robert Fratila, Kelly Perlman and Sonia Israel and is headquartered in Montréal, Canada. | 7 Jahre |
Guillermo Ruiz | M | 32 | 3 Jahre | |
Jennifer Reynolds | F | - | 2 Jahre | |
Theresa Yanofsky | F | 67 | 5 Jahre | |
John Khabbaz | M | 52 | 2 Jahre | |
Derek Stern | M | 57 | 6 Jahre | |
Paul Sweetnam | M | - |
Response Pharmaceuticals, Inc.
Response Pharmaceuticals, Inc. BiotechnologyHealth Technology Response Pharmaceuticals, Inc. is a clinical-stage therapeutic development company that focuses on developing treatments for weight management and metabolic disease. The company is based in Falls Church, VA. The company's initial clinical focus is to help people taking antipsychotic medications for disabling mental illness combat weight gain and metabolic dysregulation that is endemic with these treatments. Response is developing RDX-002 as an adjunctive therapy for patients taking first-line antipsychotic therapy. The company was founded by Eric Keller, Paul Sweetnam. Eric Keller has been the CEO since incorporation. | - |
Brian Sherman | M | - | 3 Jahre | |
France Landry | F | - | 5 Jahre | |
Scott Carroll | M | - | 2 Jahre | |
Trudie Resch | F | - |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 17 Jahre |
Luis Alberto Ibarra Prado | M | - | 3 Jahre | |
Gustavo Castellanos Lugo | M | - | - | |
Hum Matthew | M | - |
Presagia Corp.
Presagia Corp. Packaged SoftwareTechnology Services Part of Absence Soft LLC, Presagia Corp. is a cloud-based solutions provider that helps organizations solve complex health and business problems. The private company is based in Montréal, Canada. Presagia Sports is the Canadian company's world-class athlete electronic health record system, leveraged by Olympic organizations, professional sports teams, performance arts organizations, sports medicine clinics, school districts, high schools, and universities to optimize how they manage athlete health. Presagia also provides cloud-based absence management solutions that enable employers to efficiently manage employee absence while complying with more than 500 federal, state, and local leave rules and 150 Canadian federal and provincial leave rules. Presagia integrates with customers' HR systems and automates leave processes, enabling organizations to increase efficiency, minimize absence, reduce cost, and improve compliance, while providing better customer service to employees. The company was founded in 1987 by David Glickman, and René Beaudoin has been the CEO of the company since 2021. Presagia was acquired by Absence Soft LLC on November 30, 2021. | 10 Jahre |
Avi Krivorot | M | - | 3 Jahre | |
Bipasha Chiu | F | - | 3 Jahre | |
Anthony Manouk | M | - | 6 Jahre | |
Jeronimo Peralta del Valle | M | 32 | 3 Jahre | |
René Beaudoin | M | - |
Presagia Corp.
Presagia Corp. Packaged SoftwareTechnology Services Part of Absence Soft LLC, Presagia Corp. is a cloud-based solutions provider that helps organizations solve complex health and business problems. The private company is based in Montréal, Canada. Presagia Sports is the Canadian company's world-class athlete electronic health record system, leveraged by Olympic organizations, professional sports teams, performance arts organizations, sports medicine clinics, school districts, high schools, and universities to optimize how they manage athlete health. Presagia also provides cloud-based absence management solutions that enable employers to efficiently manage employee absence while complying with more than 500 federal, state, and local leave rules and 150 Canadian federal and provincial leave rules. Presagia integrates with customers' HR systems and automates leave processes, enabling organizations to increase efficiency, minimize absence, reduce cost, and improve compliance, while providing better customer service to employees. The company was founded in 1987 by David Glickman, and René Beaudoin has been the CEO of the company since 2021. Presagia was acquired by Absence Soft LLC on November 30, 2021. | 3 Jahre |
Marina Massingham | F | - |
Aifred Health, Inc.
Aifred Health, Inc. Packaged SoftwareTechnology Services Aifred Health, Inc. provides artificial intelligence to enhance treatment response in mental health. It offers treatment prediction, interpretability, patient data tracking, and electronic patient recods. The company was founded by Robert Fratila, Kelly Perlman and Sonia Israel and is headquartered in Montréal, Canada. | 11 Jahre |
Jennifer Stahlke | F | - | 3 Jahre | |
Simon Brown | M | - | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jennifer Shea | F | - | 10 Jahre | |
Michael Berendt | M | 75 |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 5 Jahre |
Nadia Jubinville | F | - | - | |
Philippe Adam | M | - | 3 Jahre | |
Mathieu Boudreau | M | - |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 2 Jahre |
Murielle Lortie | F | 54 | 2 Jahre | |
Jonathan Roiter | M | - | 2 Jahre | |
Warren Whitehead | M | 71 | - | |
Mairi Phillips | F | - | 12 Jahre | |
Albert Beraldo | M | - | 3 Jahre | |
François Vimard | M | 62 | 3 Jahre | |
Neil William Flanzraich | M | 80 | 6 Jahre | |
Gregory Gubitz | M | 66 | 1 Jahre | |
Hamnett P. Hill | M | 52 | 5 Jahre | |
Jeremy Curnock-Cook | M | 75 |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 3 Jahre |
James Moodie Rae | M | - |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 4 Jahre |
Gary Littlejohn | M | 68 |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 1 Jahre |
Brian J. Groch | M | - | 1 Jahre | |
Guy Leblanc | M | 67 | 2 Jahre | |
Alex Wolfe | M | - | - | |
Greg Christopher | M | - | - | |
Mocharla Raghavendra | M | - | 2 Jahre | |
Mohammad Awada | M | - | 4 Jahre | |
Geoffroy de Vernou | M | - | 2 Jahre | |
David Abitbol | M | - | 3 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Kanada | 60 | 96,77% |
Vereinigte Staaten | 2 | 3,23% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Donald Olds
- Persönliches Netzwerk